Physician

Adam S Plotkin, MD

According to 2025 Medicare claims, Adam Plotkin, MD (NPI: 1306896105) practices dermatology in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is ADAM S PLOTKIN MD PA (NPI: 1407805021; TIN: 592188091) and primary practice location at 33484-6500.

Plotkin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,900 traditional Medicare patients, billed 18,138 HCPCS/CPT codes, and received $1,443,618 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,568 prescription claims across 928 beneficiaries totaling $478,431 in drug costs, led by Cibinqo (Abrocitinib). DME data shows 687 claims. Open Payments data shows 48 records totaling $21,039. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $358,555 and ending at $478,431. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,309	30,497	$1,161,392
2016	3,049	29,282	$1,084,624
2017	2,965	26,856	$1,051,292
2018	2,875	24,381	$940,523
2019	2,644	25,384	$1,159,714
2020	2,333	27,384	$984,129
2021	2,101	30,132	$2,073,935
2022	2,065	24,310	$1,761,893
2023	1,936	19,563	$1,300,475
2024	1,900	18,138	$1,443,618

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,299	3,134	$358,555
2016	1,259	2,958	$251,617
2017	1,242	2,913	$255,844
2018	1,147	2,800	$243,861
2019	1,125	2,858	$332,065
2020	1,027	2,680	$350,642
2021	900	2,263	$218,551
2022	882	2,234	$362,241
2023	887	2,419	$414,040
2024	928	2,568	$478,431

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	140	144	$117,932
2024	487	687	$631,053

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,512	2,542	$98
17110	Destruction of skin growth, 1-14 growths	1,148	1,706	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	827	1,596	$69
17000	Destruction of precancer skin growth, 1 growth	1,286	2,074	$34
17003	Destruction of precancer skin growth, 2-14 growths	1,008	6,447	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cibinqo	Abrocitinib	22	660	$129,835
Ketoconazole	Ketoconazole	603	18,755	$10,466
Fluorouracil	Fluorouracil	137	4,181	$8,156
Clobetasol Propionate	Clobetasol Propionate	97	3,463	$6,561
Gentamicin Sulfate	Gentamicin Sulfate	132	2,850	$4,437

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A6010	Collagen based wound filler, dry form, sterile, per gram of collagen	N	320	474	$621,422
A6203	Composite dressing, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	N	167	213	$9,630

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$1,459	Acera Surgical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$19,580	Arcutis Biotherapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam S. Plotkin, MD?

Tedicare shows public-source Medicare data for Adam S. Plotkin, MD (NPI 1306896105), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam S. Plotkin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam S. Plotkin, MD?

Adam S. Plotkin, MD is linked to ADAM S PLOTKIN MD PA (billing NPI 1407805021) in the available physician profile data.

Does Adam S. Plotkin, MD have Open Payments data?

Adam S. Plotkin, MD has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.